[Experiments with a new ophthalmic therapeutic agent (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000009:adverse effects / Q000627:therapeutic use*; D010118:Oxytetracycline / Q000009:adverse effects / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D007093:Imidazoles; D009883:Ophthalmic Solutions; D014662:Vasoconstrictor Agents; D010118:Oxytetracycline
Therapeutische Erfahrungen mit einem neuen Ophthalmikum (Oxy Biciron)